Compound Electrolyte Injection
Function and Efficacy
The pH value of this product is 7.4, and it is a water and electrolyte supplement and alkalizer. Its gluconate and acetate are oxidized in the body and eventually metabolized into carbon dioxide and water.
Ingredients
Each 1000ml contains 5.26g sodium chloride, 5.02g sodium gluconate, 3.68g sodium acetate, 0.37g potassium chloride and 0.30g magnesium chloride.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Sodium chlorideIngredients |
Water, electrolyte supplement source and alkalizer More |
7647-14-5 | 43 | |
| Sodium gluconateIngredients |
A source of water and electrolytes and an alkalizer; gluconate is oxidized in the body and eventually metabolized into carbon dioxide and water. More |
527-07-1 | 12 | |
| Sodium acetateIngredients |
A source of water and electrolytes and an alkalizer; acetate is oxidized in the body and eventually metabolized into carbon dioxide and water More |
127-09-3 | 34 | |
| Potassium chlorideIngredients |
Water, electrolyte supplement source and alkalizer More |
7447-40-7 | 38 | |
| Magnesium chlorideIngredients |
Water, electrolyte supplement source and alkalizer More |
7786-30-3 | 23 |
Indication
This product can be used as a supplementary source of water and electrolytes and an alkalinizing agent. This product is compatible with blood and blood components and can be infused before or after blood transfusion (i.e. as a priming solution) using the same administration device, can be added to the blood components being infused, or used as a diluent for blood cells.
Usage and Dosage
Intravenous drip (sterile operation, see the instructions on the packaging bag for details): The dosage depends on the patient's age, weight, clinical symptoms and laboratory test results, and should be followed by the doctor.
Adverse Reactions
During infusion, due to the solution or operation, fever reaction, local infection at the injection site, venous thrombosis, phlebitis, fluid extravasation and excessive circulating blood volume may occur. If any adverse reaction occurs, the infusion should be stopped immediately and the patient should be evaluated to develop an appropriate treatment plan. If necessary, retain the remaining solution for testing.
Precautions
1. Adding drugs may cause incompatibility. Additives with known incompatibility should not be used. If possible, please consult a pharmacist; 2. The contraindications for the elderly, children, and pregnant women are not yet clear.
Drug Interactions
Not yet clear.
Storage
Keep tightly closed. Solutions containing added drugs must not be stored.
Packaging Specification
500ml
Manufacturer
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
-
Founded in:
1993-07-05 -
Address:
The First Pharmaceutical Park, Economic and Technological Development Zone, Datong City, Shanxi Province -
Tax NO.:
91140200602165291J -
Registered Funds:
395 million yuan -
Website:
-
Email: